Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cirrhotic Cardiomyopathy: A New Clinical Phenotype.

Literature DB >> 28699978

Cirrhotic Cardiomyopathy: A New Clinical Phenotype.

Luis Otávio Cardoso Mocarzel¹, Mariana Macedo Rossi¹, Bruna de Mello Miliosse¹, Pedro Gemal Lanzieri¹, Ronaldo Altenburg Gismondi¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2017 PMID： 28699978 PMCID： PMC5489327 DOI： 10.5935/abc.20170066

Source DB: PubMed Journal: Arq Bras Cardiol ISSN： 0066-782X Impact factor: 2.000

× No keyword cloud information.

20 in total

Review 1. Cirrhosis and chronic liver failure: part II. Complications and treatment.

Authors: Joel J Heidelbaugh; Maryann Sherbondy
Journal: Am Fam Physician Date: 2006-09-01 Impact factor: 3.292

Review 2. Pathophysiological and clinical approach to cirrhotic cardiomyopathy.

Authors: Alida Páll; Arpád Czifra; Zsuzsanna Vitális; Mária Papp; György Paragh; Zoltán Szabó
Journal: J Gastrointestin Liver Dis Date: 2014-09 Impact factor: 2.008

Review 3. Cirrhotic cardiomyopathy.

Authors: Enrico M Zardi; Antonio Abbate; Domenico Maria Zardi; Aldo Dobrina; Domenico Margiotta; Benjamin W Van Tassell; Benjamin W Van Tassel; Antonella Afeltra; Arun J Sanyal
Journal: J Am Coll Cardiol Date: 2010-08-10 Impact factor: 24.094

4. Cirrhotic cardiomyopathy.

Authors: Florence Wong
Journal: Hepatol Int Date: 2008-11-11 Impact factor: 6.047

5. Cardiac and proinflammatory markers predict prognosis in cirrhosis.

Authors: Signe Wiese; Christian Mortensen; Jens P Gøtze; Erik Christensen; Ove Andersen; Flemming Bendtsen; Søren Møller
Journal: Liver Int Date: 2014-01-07 Impact factor: 5.828

Review 6. Cirrhotic Multiorgan Syndrome.

Authors: Søren Møller; Flemming Bendtsen
Journal: Dig Dis Sci Date: 2015-06-26 Impact factor: 3.199

7. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors: J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal: Gut Date: 2003-10 Impact factor: 23.059

Cirrhotic Cardiomyopathy: A New Clinical Phenotype.

Review 1. Cirrhosis and chronic liver failure: part II. Complications and treatment.

Review 2. Pathophysiological and clinical approach to cirrhotic cardiomyopathy.

Review 3. Cirrhotic cardiomyopathy.

4. Cirrhotic cardiomyopathy.

5. Cardiac and proinflammatory markers predict prognosis in cirrhosis.

Review 6. Cirrhotic Multiorgan Syndrome.

7. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

8. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.

9. Cirrhotic cardiomyopathy: Isn't stress evaluation always required for the diagnosis?

10. Hepatorenal syndrome with cirrhotic cardiomyopathy: case report and literature review.

1. Role of Anti-Beta-1-Adrenergic Receptor Antibodies in Cardiac Dysfunction in Patients with Cirrhotic Cardiomyopathy.